This book acquaints students and practitioners in the related fields of pharmaceutical sciences, clinical trials, and evidence-based medicine with the necessary study design concepts and statistical practices to allow them to understand how drug developers plan and evaluate their drug development. T
New drug development : design, methodology, and analysis
โ Scribed by J Rick Turner
- Publisher
- Wiley-Interscience
- Year
- 2007
- Tongue
- English
- Leaves
- 297
- Series
- Statistics in practice
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
'New Drug Development' acquaints students and practitioners in the related fields of pharmaceutical sciences, clinical trials, and evidence-based medicine with the necessary study design concepts and statistical practices to allow them to understand how drug developers plan and evaluate their drug development.
โฆ Table of Contents
Content: New drug development --
The regulatory environment for new drug development --
Drug discovery --
Nonclinical research --
Design and methodology in clinical trials --
Statistical analysis --
Statistical significance : employment of hypothesis testing --
Clinical significance : employment of confidence intervals --
Sample-size estimation --
Safety assessment in clinical trials --
Efficacy assessment in clinical trials --
Pharmaceutical and biopharmaceutical drug manufacturing --
Postmarketing surveillance and evidence-based medicine --
Unifying themes and concluding comments.
Abstract: 'New Drug Development' acquaints students and practitioners in the related fields of pharmaceutical sciences, clinical trials, and evidence-based medicine with the necessary study design concepts and statistical practices to allow them to understand how drug developers plan and evaluate their drug development
๐ SIMILAR VOLUMES
This book acquaints students and practitioners in the related fields of pharmaceutical sciences, clinical trials, and evidence-based medicine with the necessary study design concepts and statistical practices to allow them to understand how drug developers plan and evaluate their drug development. T
These multidisciplinary presentations provide information essential to devising effective drug protocols in cardiovascular drug development, facilitating the approval process. Guides researchers and developers through the government drug approval process, facilitating development, minimizing costs,
Based on topics presented at the Annual Japanese (Quantitative) Structure-Activity Relationship Symposium and the Biennial China-Japan Drug Design and Development conference, the topics in this volume cover almost every procedure and subdiscipline in the SAR discipline. They are categorized in three
Based on topics presented at the Annual Japanese (Quantitative) Structure-Activity Relationship Symposium and the Biennial China-Japan Drug Design and Development conference, the topics in this volume cover almost every procedure and subdiscipline in the SAR discipline. They are categorized in three
These multidisciplinary presentations provide information essential to devising effective drug protocols in cardiovascular drug development, facilitating the approval process. Guides researchers and developers through the government drug approval process, facilitating development, minimizing costs,